Reversible binding is essential for affinity chromatography. We discuss how to ensure you meet this critical property when developing aptamers for aptamer-based affinity chromatography applications. In developing affinity chromatography…
Affinity binders are the workhorses of assays and methods across the life sciences. From biologics to bioprocessing ligands and research reagents, the requirements for affinity binders vary according to…
Your research is unique. We tailor your Optimer discovery strategy to match, delivering the highest chance of success and the best Optimer performance. Download this booklet to learn how: …
Not all protein-binding aptamers are developed equally. And they shouldn’t be. When developing aptamers to protein targets the ‘how’ is just as important as the ‘what’. The ‘what’ is what…
Aptamers are enabling new therapeutics, new diagnostics and the pursuit of new targets. In this on-demand panel discussion experts from industry and academia cover the latest developments in aptamer…
From drug screening to critical assay reagents and as targeted therapeutics, aptamers are increasingly being employed across the discovery and development pipeline. Despite the large catalogues of antibodies, aptamers and…
Accelerating your journey to clinic is crucial in life sciences, where speeding project timelines can make all the difference. Optimer offers an antibody alternative that can cut up to…
In the age of the reproducibility crisis, working with affinity tools that offer the highest batch consistency is critical for the development of robust assays and reliable data. Aptamers,…
New research shows how Optimer can speed projects by up to 75% compared to standard antibodies. Speeding project timelines can be vital to the development of any life science product. Whether…
Optimer binders are oligonucleotide-based affinity ligands that are being employed to offer new bioprocessing solutions. Isolated from large degenerate libraries, they can bind to a range of protein and…
